| Condensed Statements of Income |
Condensed Statements of Income | | | | | | | | | | | | | | | | | | | Year Ended December 31, | 2025 | | 2024 | | 2023 | | Interest revenue | $ | 509 | | | $ | 628 | | | $ | 545 | | | Interest expense | (883) | | | (837) | | | (717) | | | Net interest expense | (374) | | | (209) | | | (172) | | | | | | | | | Other revenue | 15 | | | — | | | — | | | Expenses Excluding Interest: | | | | | | | Professional services | (24) | | | (34) | | | (21) | | | Regulatory fees and assessments | (12) | | | (14) | | | (16) | | | Compensation and benefits | (5) | | | (6) | | | (8) | | | Other expenses excluding interest | (109) | | | (139) | | | (112) | | | Loss before income tax benefit and equity in net income of subsidiaries | (509) | | | (402) | | | (329) | | | Taxes on income | 77 | | | 74 | | | 60 | | | Loss before equity in net income of subsidiaries | (432) | | | (328) | | | (269) | | | Equity in net income of subsidiaries: | | | | | | | Equity in undistributed net income (distributions in excess of net income) of subsidiaries | (3,896) | | | 3,838 | | | 1,318 | | | Dividends from bank subsidiaries | 8,065 | | | 185 | | | — | | | Dividends from non-bank subsidiaries | 5,115 | | | 2,247 | | | 4,018 | | | Net Income | 8,852 | | | 5,942 | | | 5,067 | | Preferred stock dividends and other | 435 | | | 464 | | | 418 | | | Net Income Available to Common Stockholders | $ | 8,417 | | | $ | 5,478 | | | $ | 4,649 | |
|
| Condensed Balance Sheets |
Condensed Balance Sheets | | | | | | | | | | | | | December 31, | 2025 | | 2024 | | Assets | | | | | Cash and cash equivalents | $ | 12,829 | | | $ | 10,538 | | | Receivables from subsidiaries | 1,385 | | | 1,319 | | | Available for sale securities | 2,043 | | | 1,980 | | | | | | | | | | | Loans to non-bank subsidiaries | 750 | | | — | | | Investment in non-bank subsidiaries | 35,086 | | | 34,075 | | | Investment in bank subsidiaries | 21,418 | | | 22,638 | | | Other assets | 932 | | | 866 | | | Total assets | $ | 74,443 | | | $ | 71,416 | | | Liabilities and Stockholders’ Equity | | | | | Accrued expenses and other liabilities | $ | 1,002 | | | $ | 751 | | | Payables to subsidiaries | 74 | | | 78 | | | Short-term borrowings | 1,863 | | | — | | | Long-term debt | 22,079 | | | 22,212 | | | Total liabilities | 25,018 | | | 23,041 | | | Stockholders’ equity | 49,425 | | | 48,375 | | | Total liabilities and stockholders’ equity | $ | 74,443 | | | $ | 71,416 | |
|
| Condensed Statements of Cash Flows |
Condensed Statements of Cash Flows | | | | | | | | | | | | | | | | | | | Year Ended December 31, | 2025 | | 2024 | | 2023 | | Cash Flows from Operating Activities | | | | | | | Net income | $ | 8,852 | | | $ | 5,942 | | | $ | 5,067 | | | Adjustments to reconcile net income to net cash provided by (used for) operating activities: | | | | | | | Dividends in excess of (equity in undistributed) earnings of subsidiaries | 3,896 | | | (3,838) | | | (1,318) | | | Other | (6) | | | (64) | | | (35) | | | Net change in: | | | | | | | | | | | | | Other assets | 28 | | | (175) | | | (106) | | | Payables to brokers, dealers, and clearing organizations | 3 | | | — | | | — | | | Accrued expenses and other liabilities | 161 | | | 31 | | | 77 | | | Net cash provided by (used for) operating activities | 12,934 | | | 1,896 | | | 3,685 | | | Cash Flows from Investing Activities | | | | | | | Due from (to) subsidiaries — net | 300 | | | 862 | | | (174) | | | Return of (increase in) investments in subsidiaries | 187 | | | 2,205 | | | (2,720) | | | | | | | | | Repayments (advances) of subordinated loan to CS&Co | (750) | | | — | | | — | | | Purchases of available for sale securities | (4,475) | | | (2,985) | | | (1,486) | | | Proceeds from sales of available for sale securities | 1,469 | | | 1 | | | — | | | Principal payments on available for sale securities | 3,003 | | | 3,048 | | | 3,721 | | | | | | | | | Other investing activities | (53) | | | (24) | | | (7) | | | Net cash provided by (used for) investing activities | (319) | | | 3,107 | | | (666) | | | Cash Flows from Financing Activities | | | | | | | | | | | | | | | | | | | Proceeds from short-term borrowings | 3,865 | | | — | | | 344 | | | Repayments of short-term borrowings | (2,055) | | | — | | | (598) | | | Issuances of long-term debt | 1,986 | | | — | | | 6,097 | | | Repayments of long-term debt | (2,143) | | | (3,600) | | | (800) | | | Repurchases of common stock and nonvoting common stock | (7,346) | | | — | | | (2,842) | | | | | | | | | Redemption and repurchase of preferred stock | (2,458) | | | — | | | (467) | | | Dividends paid | (2,329) | | | (2,275) | | | (2,276) | | | Proceeds from stock options exercised | 156 | | | 84 | | | 49 | | | | | | | | | Net cash provided by (used for) financing activities | (10,324) | | | (5,791) | | | (493) | | | Increase (Decrease) in Cash and Cash Equivalents | 2,291 | | | (788) | | | 2,526 | | | Cash and Cash Equivalents at Beginning of Year | 10,538 | | | 11,326 | | | 8,800 | | | Cash and Cash Equivalents at End of Year | $ | 12,829 | | | $ | 10,538 | | | $ | 11,326 | | | | | | | | | | | | | | | | | | | |
|